DIFFERENTIAL EFFICACY OF BORTEZOMIB IN SUBTYPES OF DIFFUSE LARGE B-CELL LYMPHOMA (DLBL): a PROSPECTIVE RANDOMISED STUDY STRATIFIED BY TRANSCRIPTOME PROFILING: REMODL-B

Davies, A.J.; Barrans, S.; Maishman, T.; Cummin, T.E.; Bentley, M.; Mamot, C.; Novak, U.; Caddy, J.; Hamid, D.; Kazmi-Stokes, S.H.; Mcmillan, A.; Fields, P.A.; Pocock, C.; Kruger, A.; Collins, G.; Sha, C.; Clipson, A.; Wang, M.; Tooze, R.M.; Care, M.A.; Griffiths, G.O.; Du, M.; Westhead, D.R.; Burton, C.; Jack, A.; Johnson, P.W.

doi:10.1002/hon.2437_120

Back

Journal article

DIFFERENTIAL EFFICACY OF BORTEZOMIB IN SUBTYPES OF DIFFUSE LARGE B-CELL LYMPHOMA (DLBL): a PROSPECTIVE RANDOMISED STUDY STRATIFIED BY TRANSCRIPTOME PROFILING: REMODL-B

Davies, A.J. Cancer Research UK Centre; University of Southampton (PMAL Consortium); Southampton UK
Barrans, S. Haematological Malignancy Diagnostic Service, Haematological Malignancy Diagnostic Service; St. James's Institute of Oncology, Leeds; Leeds UK
Maishman, T. Southampton Clinical Trials Unit; University of Southampton; Southampton UK
Cummin, T.E. Cancer Research UK Centre; University of Southampton (PMAL Consortium); Southampton UK
Bentley, M. School of Molecular and Cellular Biology; University of Leeds; Leeds UK
Mamot, C. Swiss Group for Clinical Cancer Research (SAKK); Kantonsspital Aarau; Bern Switzerland
Novak, U. Swiss Group for Clinical Cancer Research (SAKK); Inselspital / Bern University Hospital; Bern Switzerland
Caddy, J. Cancer Research UK Centre; University of Southampton (PMAL Consortium); Southampton UK
Hamid, D. Southampton Clinical Trials Unit; University of Southampton; Southampton UK
Kazmi-Stokes, S.H. Cancer Research UK Centre; University of Southampton (PMAL Consortium); Southampton UK
Mcmillan, A. Haematology; Nottingham City Hospital; Nottingham UK
Fields, P.A. Haematology; Guy's and St Thomas' and King's College Hospitals; London UK
Pocock, C. Haematology; East Kent Hospitals University NHS Trust; Canterbury UK
Kruger, A. Haematology; Royal Cornwall Hospital; Truro UK
Collins, G. Clinical Haematology; Churchill Hospital; Oxford UK
Sha, C. Bioinformatics group, IMCB; University of Leeds; Leeds UK
Clipson, A. Division of Molecular Histopathology; University of Cambridge; Cambridge UK
Wang, M. Division of Molecular Histopathology; University of Cambridge; Cambridge UK
Tooze, R.M. Faculty of Medicine and Health; University of Leeds; Leeds UK
Care, M.A. Faculty of Medicine and Health; University of Leeds; Leeds UK
Griffiths, G.O. Southampton Clinical Trials Unit; University of Southampton; Southampton UK
Du, M. Division of Molecular Histopathology; University of Cambridge; Cambridge UK
Westhead, D.R. School of Molecular and Cellular Biology; University of Leeds; Leeds UK
Burton, C. Haematological Malignancy Diagnostic Service, Haematological Malignancy Diagnostic Service; St. James's Institute of Oncology, Leeds; Leeds UK
Jack, A. Haematological Malignancy Diagnostic Service, Haematological Malignancy Diagnostic Service; St. James's Institute of Oncology, Leeds; Leeds UK
Johnson, P.W. Cancer Research UK Centre; University of Southampton (PMAL Consortium); Southampton UK

2017-6-7

Published in:

Hematological Oncology. - Wiley. - 2017, vol. 35, p. 130-131

Language

English

Open access status

bronze

Identifiers

DOI 10.1002/hon.2437_120
ISSN 0278-0232

Persistent URL

https://sonar.ch/global/documents/284107

Statistics

Document views: 26 File downloads:

fulltext.pdf: 0